Patent details

Basic Information

Publication number:

91365

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP999249295

Legal Status:

Expired

Application number:

91365

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/07/386/001-EU/1/07/386/010 TOVIAZ-fésotérodin

Marketing Authorization Type:

Marketing Authorization Date:

24/04/2007

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

14/09/2007

First Marketing Authorization date:

24/04/2007

Grant date:

14/11/2007

Activation date:

11/05/2019

Publication date:

14/11/2007

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

24/04/2022

SPC Extension Expiration:

24/04/2022

Rejection date:

Withdrawal date:

Owner

From:

30/08/2017

 

 

Name:

UCB Pharma GmbH

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

History of Owners

From:

14/09/2007

To:

30/08/2017

Name:

SCHWARZ PHARMA AG

Address:

ALFRED-NOBEL-STRASSE 10, 40789, MONHEIM, Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

14/09/2007

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SPARF Bengt

Address:

Sweden (SE)

2

Name:

MEESE Claus

Address:

Germany (DE)

Licencee

Name:

Pfizer Inc.

From:

30/08/2017

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

To:

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2017/05

Publication date:

13/09/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

MED

Bulletin edition number:

2017/06

Publication date:

10/10/2017

Description:

Section K : Modifications and recordals into the register

3

Bulletin Heading:

SPC4

Bulletin edition number:

2019/01

Publication date:

09/01/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

4

Bulletin Heading:

SPC3

Bulletin edition number:

2019/07

Publication date:

11/06/2019

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000323A

Date Registered:

30/08/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Office FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

UCB Pharma GmbH

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Removed Pledgee

Name:

Address:

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20170000324E

Date Registered:

30/08/2017

Licence Effective Date:

05/01/2017

Licence Expiration Date:

Scope of Licence:

Exclusive

Deed Filer:

Office FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

22/03/2021

Last Annual Fee Paid Number:

23

Last Annual Fee Paid Amount:

430 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
31/12/2018	Outgoing Correspondence	1
31/12/2018	Publication	1
30/08/2017	Request For Change	1
07/09/2017	Outgoing Correspondence	1
30/08/2017	Request For Change	4
17/02/2016	Incoming Correspondence (Post)	2